OICR News / Tag

Johnson & Johnson

Browse news tagged Johnson & Johnson.

Browse all news

Filters

Discover the latest news and insightsDiscover the latest news and insights

All Collaboration Commercialization Talent Technology

All Video Article

Tagged stories

Commercialization

FACIT-Seeded Fusion Pharmaceuticals Closes US$25M Series A Led by Johnson & Johnson Innovation

Financing leverages and strengthens Ontario’s next-generation radiotherapeutics expertise, products TORONTO, ON (February 23, 2017) – The Fight Against Cancer Innovation Trust (FACIT) and the Ontario Institute for Cancer Research (OICR) are pleased to report…

ArticleFeb 23, 2017

CommercializationBlood cancers

OICR partnership with Johnson and Johnson to develop new treatments for haematological cancers

Development of a set of novel therapeutic compounds identified by OICR’s Drug Discovery Program and researchers at the University Health Network (UHN) will be accelerated thanks to a recently announced collaboration between Johnson & Johnson…

ArticleDec 29, 2015

CommercializationBlood cancers

OICR, UHN, Novera Therapeutics Announce Collaboration with Johnson & Johnson Innovation on Drug Discovery and Development for Haematological Cancers

Research Collaboration and Option and License Agreement Reach Approximately $450 Million Cdn TORONTO, Oct. 14, 2015 /CNW/ - The Ontario Institute for Cancer Research ("OICR") together with Novera Therapeutics Inc., ("Novera") have announced a collaboration with Janssen Biotech,…

ArticleOct 14, 2015

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Johnson & Johnson

Discover the latest news and insightsDiscover the latest news and insights

Tagged stories

FACIT-Seeded Fusion Pharmaceuticals Closes US$25M Series A Led by Johnson & Johnson Innovation

OICR partnership with Johnson and Johnson to develop new treatments for haematological cancers

OICR, UHN, Novera Therapeutics Announce Collaboration with Johnson & Johnson Innovation on Drug Discovery and Development for Haematological Cancers

Cancer solved together — in your inbox